Press "esc" to clear
Go to Advanced Search

Showing results

110 of 3178
Embargo will expire:
23-Oct-2018 8:45 AM EDT
Released to reporters:
19-Oct-2018 12:05 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 23-Oct-2018 8:45 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
23-Oct-2018 2:30 PM EDT
Released to reporters:
18-Oct-2018 10:05 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 23-Oct-2018 2:30 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Stroke_Findings10-18-18.jpg
  • Embargo expired:
    18-Oct-2018 10:05 AM EDT

Article ID: 702304

Surgery Technique Reduces Strokes in Atherosclerosis Patients

Cedars-Sinai

A surgical technique called EDAS (encephaloduroarteriosynangiosis) significantly decreases the rate of stroke recurrence and death for patients with severe atherosclerosis of the brain arteries, according to findings of a Phase IIa clinical trial to be presented Oct. 18 at the World Stroke Congress in Montreal.

Released:
16-Oct-2018 2:05 PM EDT
  • Embargo expired:
    17-Oct-2018 5:00 PM EDT

Article ID: 701653

American Society of Anesthesiologists names Linda J. Mason, M.D., FASA, new president

American Society of Anesthesiologists (ASA)

SAN FRANCISCO – Linda J. Mason, M.D., FASA, director of pediatric anesthesiology at Loma Linda University Medical Center and professor of anesthesiology and pediatrics at Loma Linda University, California, was today named president of the American Society of Anesthesiologists (ASA), the nation’s largest organization of physician anesthesiologists. Dr. Mason assumed office at the ANESTHESIOLOGY® 2018 annual meeting in San Francisco and will serve for one year.

Released:
8-Oct-2018 8:00 AM EDT

Article ID: 701042

Revolutionary Noninvasive Therapy Shows Promise for Immunotherapy and Opening Blood-Brain Barrier to Enable Treatment of Neurological Disease and Cancer

Focused Ultrasound Foundation

A briefing featuring key data presented at the 6th International Symposium on Focused Ultrasound. Researchers and clinicians will highlight breakthrough advances in the use of focused ultrasound in cancer immunotherapy and for opening the blood-brain barrier (BBB).

Released:
17-Oct-2018 3:30 PM EDT
Embargo will expire:
22-Oct-2018 4:00 PM EDT
Released to reporters:
17-Oct-2018 1:00 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 22-Oct-2018 4:00 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
22-Oct-2018 4:00 PM EDT
Released to reporters:
17-Oct-2018 12:05 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 22-Oct-2018 4:00 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
23-Oct-2018 6:00 PM EDT
Released to reporters:
17-Oct-2018 12:00 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 23-Oct-2018 6:00 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Article ID: 702325

High-Dose Radiation Therapy Substantially Improves Survival in Patients Once Thought to Be Incurable

American Society for Radiation Oncology (ASTRO)

In the first randomized, phase II clinical trial of its kind, researchers have shown that an aggressive form of high-precision radiation therapy can greatly increase how long oligometastatic patients live and doubles how long they live without cancer. The findings will be presented in a news briefing and the plenary session at the 60th Annual Meeting of the American Society for Radiation Oncology (ASTRO) next week.

Released:
17-Oct-2018 8:30 AM EDT
Embargo will expire:
20-Oct-2018 5:30 PM EDT
Released to reporters:
16-Oct-2018 2:30 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 20-Oct-2018 5:30 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

110 of 3178

Chat now!